Blood Pressure Phenotype Variations at Different Gestational Stages and Associated Pregnancy Risks
American Journal of Hypertension · 2025
DOI: 10.1093/ajh/hpaf038 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, 2025. Verfasst von Lushu Zuo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Blood Pressure, Hypertension, Pregnancy-Induced, White Coat Hypertension, Masked Hypertension. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND Hypertensive disorders of pregnancy (HDP) significantly increase the risk of adverse pregnancy outcomes (APOs). Blood pressure (BP) phenotypes, including masked hypertension (MH), white-coat hypertension (WCH), sustained hypertension (SH), and normotension, are identified through office BP (OBP) and ambulatory BP (ABP) monitoring. The proportion of BP phenotypes at different gestational age and their associations with APOs are not well understood. METHODS AND RESULTS This retrospective study included 967 women at high risk or diagnosed with HDP who underwent OBP and ABP measurement at different gestational stages [0-19+6 (n = 150), 20+0-29+6 (n = 221), 30+0-32+6 (n = 135), 33+0-35+6 (n = 185), and ≥36+0 gestational weeks (GW) (n = 276)]. Women with ABP monitored at 20+0-29+6 GW had the lowest BP levels corresponding to the highest prevalence of NT. Compared to OBP, hypertension determined by ABP demonstrated stronger and more consistent associations with APOs, defined as a composite of maternal (e.g., severe preeclampsia, preterm birth) and fetal (pregnancy loss and SGA infants) outcomes. SH was consistently associated with the highest risk for APOs, with risk decreasing as gestation advanced after 20+0 GW. MH was significantly associated with APOs, particularly between 30+0 and 32+6 GW. WCH had no association with fetal outcomes at any gestational stage. CONCLUSION The associations between BP phenotypes and APOs differ across gestational stages. SH detected earlier in pregnancy carries the highest risks, while WCH is generally benign for fetal outcomes. These findings highlight the critical role of ABP monitoring in BP phenotyping and underscore the need for gestational-stage-specific diagnostic thresholds to enable tailored interventions and optimize APOs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, China.
- Medical Genetic Center and Department of Obstetrics, Guangdong Women and Children Hospital, Guangzhou, China.
- Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China.
- Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zuo, L., Fang, Y., Li, L., Duan, H., Wen, J., Yang, Q., Han, C., Lv, L., & Zhou, X. (2025). Blood Pressure Phenotype Variations at Different Gestational Stages and Associated Pregnancy Risks. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf038
Vancouver
Zuo L, Fang Y, Li L, Duan H, Wen J, Yang Q, et al. Blood Pressure Phenotype Variations at Different Gestational Stages and Associated Pregnancy Risks. American Journal of Hypertension. 2025. doi:10.1093/ajh/hpaf038
BibTeX
@article{Zuo2025,
author = {Zuo, Lushu and Fang, Yiwen and Li, Linjie and Duan, Hongli and Wen, Jiying and Yang, Qing and Han, Cha and Lv, Lijuan and Zhou, Xin},
title = {Blood Pressure Phenotype Variations at Different Gestational Stages and Associated Pregnancy Risks},
journal = {American Journal of Hypertension},
year = {2025},
doi = {10.1093/ajh/hpaf038}
}
EUVIMED